Posts by Brian Westerlind
Changes are Coming to Product Labels
By Alvin J. Lorman, AAHP counsel August 1, 2017 Changes are coming to your products’ labels. Not only are there changes to the Homeopathic Pharmacopeia of the United States (HPUS)…
Read MoreFDA’s Division of Nonprescription Drug Products
By Mark Land, AAHP president August 1, 2017 The development and regulation of over-the-counter (OTC) drug products is the responsibility of the Division of Nonprescription Drug Products (DNDP) within the…
Read MoreOTC Monograph Reform
By Mark Land, AAHP president August 1, 2017 Self-medication is an important way in which American consumers treat many types of illnesses. Over-the-counter (OTC) drugs often provide effective relief in…
Read MoreAAHP Highlights Expanded Homeopathic Drug Manufacturing Best Practices
MILWAUKIE, Ore. (July 20, 2017) – The American Association of Homeopathic Pharmacists (AAHP) recently hosted a webinar on 2017 improvements to the Homeopathic Pharmacopeia of the United States (HPUS). Highlighting…
Read MoreCongress Aiming to Consider User Fee Legislation in July
By Pete Evich, AAHP government relations July 1, 2017 Bills (S 934, HR 2430) that would renew the Food and Drug Administration’s (FDA) ability to collect fees from the drug…
Read MorePDUFA after 25 Years
By Mark Land, AAHP president July 1, 2017 The Prescription Drug User Fee Authorization (PDUFA) first enacted in 1992 was the third major piece of drug legislation in the modern…
Read MoreStability Considerations of Homeopathic Drugs
By Mary Beth Watkins, AAHP Vice President The history of homeopathy has demonstrated that many homeopathic tinctures and low-potency dosage forms are remarkably stable. Archived homeopathic tinctures and potencies, when…
Read MoreCommunications Best Practices: Anticipating Questions
By Alissa Gould, public relations manager, Boiron USA July 1, 2017 Since April 2017, AAHP has offered a series of articles on good communication practices that can be applied to…
Read MoreThe Homeopathic Pharmacopoeia of the United States
By Mark Land, AAHP president June 1, 2017 The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and…
Read More2017 Updates in the Homeopathic Pharmacopeia
By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Before proceeding to review the major areas of updates in the HPUS, two specific items are of timely interest:…
Read More